drugset / Trial / NCT00862875
Levemir-Body Composition and Energy Metabolism
Phase 4
Completed
42 enrolled
Montreal Clinical Research Institute
McMaster University · collabNovo Nordisk A/S · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The objectives is to compare the changes in body composition (primary objective), diabetes parameters, energy expenditure and energy intake between Insulin detemir (Levemir® - Novolin® 4 pen) and insulin glargine (Lantus® - Solostar®) both in combination with Metformin and insulin secretagogues (SU) between baseline and after 6 months of insulin therapy in 80 type 2 diabetic patients failing on oral diabetic agents .
Timeline
- Start
- 2009-03
- Primary completion
- 2014-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin detemir | Protein / enzyme biologic | 10 iu | — |
| Subject | insulin glargine | Protein / enzyme biologic | 10 iu | — |